Intraductal carcinoma
Showing 1 - 25 of 7,937
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy
Completed
- Ductal Carcinoma in Situ
- Mastectomy with sentinel lymph node biopsy
- (no location specified)
Jul 17, 2023
Abbreviated Breast MRI After BCT
Active, not recruiting
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
-
Philadelphia, PennsylvaniaUPenn
Nov 18, 2022
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Breast Tumors Trial in Benxi, Shengyang, Shenyang (Expanded Mckissock surgery, Modified radical mastectomy)
Recruiting
- Breast Neoplasms
- Expanded Mckissock surgery
- Modified radical mastectomy
-
Benxi, Liaoning, China
- +2 more
Feb 6, 2022
Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active
Completed
- Ductal Carcinoma in Situ
- Decision Support Tool with Active Monitoring
- Decision Support Tool without Active Monitoring
-
Durham, North CarolinaDuke Mammography Clinic
Jan 4, 2023
Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)
Not yet recruiting
- Breast Cancer - Ductal Carcinoma in Situ (DCIS)
- Breast-Conserving Surgery
- Histolog Scanner
- (no location specified)
Jul 6, 2023
Female Breast Carcinoma, Female Ductal Carcinoma In Situ Trial in Baltimore, New York (Fulvestrant)
Terminated
- Female Breast Carcinoma
- Female Ductal Carcinoma In Situ
-
Baltimore, Maryland
- +1 more
Mar 15, 2022
Prostate Cancer Trial in Chengdu (Abiraterone acetate, Prednisolone, Goserelin)
Not yet recruiting
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Feb 3, 2021
Molecular Analysis of the Sloane Project
Enrolling by invitation
- DCIS
- +3 more
-
London, United KingdomKing's College London
May 11, 2023
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)
Not yet recruiting
- BRCA Mutation
- +3 more
- Tamoxifen 10 Mg Tablet
- +2 more
-
Genoa, Italy
- +3 more
Sep 11, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Breast Cancer, Ductal Carcinoma in Situ Trial in Basking Ridge, Commack, New York (MRI)
Active, not recruiting
- Breast Cancer
- Ductal Carcinoma in Situ
- MRI
-
Basking Ridge, New Jersey
- +2 more
Nov 7, 2022
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +5 more
- Intraoperative Imaging
- Lumpectomy
-
Chicago, Illinois
- +3 more
Nov 30, 2022
Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland
Recruiting
- Hereditary Pancreatic Carcinoma
- +2 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Aug 16, 2022
Breast Cancer, Ductal Carcinoma in Situ Trial in New York (Intranasal Oxytocin)
Suspended
- Breast Cancer
- Ductal Carcinoma in Situ
- Intranasal Oxytocin
-
New York, New YorkColumbia University Medical Center
Jul 28, 2022
Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,
Recruiting
- Acinar Cell Carcinoma
- +7 more
- Pancreatectomy
- Lavage
-
Cleveland, Ohio
- +1 more
Sep 7, 2022
Flat Epithelia Atypia, Intraductal Papilloma Without Atypia Trial in United States (Pathologic evaluation of excised tissue)
Active, not recruiting
- Flat Epithelia Atypia
- Intraductal Papilloma Without Atypia
- Pathologic evaluation of excised tissue
-
Birmingham, Alabama
- +17 more
Jan 28, 2022
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,
Active, not recruiting
- Deleterious BRCA1 Gene Mutation
- +5 more
- Behavioral, Psychological or Informational Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Duration on Clinical Outcome of HR+ Intraductal Carcinoma of
Active, not recruiting
- Breast Cancer
- Tamoxifen
- +4 more
-
Shenyang, Liaoning, ChinaThe First Hospital of China Medical University
Dec 10, 2020
Ductal Carcinoma in Situ, Invasive Ductal Carcinoma of Female Breast Trial in Stuart, Tampa (stereotactic body radiation
Recruiting
- Ductal Carcinoma in Situ
- Invasive Ductal Carcinoma of Female Breast
- stereotactic body radiation therapy
-
Stuart, Florida
- +1 more
Aug 3, 2022
Breast Cancer, Ductal Carcinoma in Situ, Invasive Breast Cancer Trial in Milwaukee (Deep Inspiration Breath Hold during
Completed
- Breast Cancer
- +2 more
- Deep Inspiration Breath Hold during Radiation
- Free breathing during radiation
-
Milwaukee, WisconsinFroedtert Hospital and Medical College of Wisconsin
Aug 1, 2022